Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
The aim of this study is to test if combining the antidepressant Citalopram with
Pentoxifylline (PTX), a medicine with anti-inflammatory and phosphodiesterase inhibitory
properties, enhanced antidepressant efficacy in adult patients with major depressive disorder
(MDD) when compared to Citalopram alone.